Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc > FDA

<< Previous

Bullboard Posts

Next >>

Comment by Nonesense64on Oct 31, 2020 4:24pm

224 Views

Post# 31819016

RE:RE:RE:RE:FDA

That's been the problem all along with this play. People making assumptions like they are true. Pumping it to the heavens . Abingdon has not been officially disclosed as Sona's partner, to my knowledge. If so, why would the CEO say that manufacturing was limited? Both the FDA and HC would have know this from the start. Abingdon is a 3 billion dollar company able to handle substantial orders, if not themselves, then through to their various contracts . Perhaps, the fears and disappointments are not misplaced after all. The truth is, we don't know shi*t right now and what is going to happen. Only speculation.

<< Previous

Bullboard Posts

Next >>

Micromem prepares ARTRA for natural gas field trials